API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/us-fda-approves-cystadrops-cysteamine-ophthalmic-solution-0-37-a-new-practical-treatment-option-for-the-ocular-manifestations-of-cystinosis-301118026.html
https://www.biospace.com/article/releases/horizon-therapeutics-plc-announces-availability-of-procysbi-cysteamine-bitartrate-delayed-release-oral-granules-in-packets-in-the-united-states/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-25-2018-1524633895.pdf
https://www.raps.org/news-and-articles/news-articles/2018/3/canadian-government-is-investigating-price-of-gene?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=BieN4
https://www.statnews.com/pharmalot/2018/03/26/canada-horizon-pharma-rare-disease-drug/?utm_source=STAT+Newsletters&utm_campaign=45ae6f1d65-Pharmalot&utm_medium=email&utm_term=0_8cab1d7961-45ae6f1d65-150630089
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-7-2018-1520410330.pdf